A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/25/2011	US20110206744 Modafinil formulations
08/25/2011	US20110206743 Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
08/25/2011	US20110206741 DHA Triglyceride Emulsions
08/25/2011	US20110206739 Compositions and methods for the preparation of nanoemulsions
08/25/2011	US20110206734 Hybrid scfa-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
08/25/2011	US20110206719 Immunostimulatory oligoribonucleotides
08/25/2011	US20110206703 Gene signature for predicting prognosis of patients with solid tumors
08/25/2011	US20110206689 Molecular Determinants Associated With Prostate Cancer And Methods Of Use Thereof
08/25/2011	US20110206685 Screening assays for inhibitors of a staphylococcus aureus siderophore
08/25/2011	US20110206673 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
08/25/2011	US20110206671 Axon regeneration promoter
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	US20110206667 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment
08/25/2011	US20110206666 Targeting pax2 for the treatment of breast cancer
08/25/2011	US20110206665 Targeting pax2 for the treatment of breast cancer
08/25/2011	US20110206661 Trimethoxyphenyl inhibitors of tyrosine kinase
08/25/2011	US20110206659 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
08/25/2011	US20110206657 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
08/25/2011	US20110206653 Tetrazole compounds for reducing uric acid
08/25/2011	US20110206638 Compositions and methods for reducing the mutation rate of viruses
08/25/2011	US20110206636 Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus
08/25/2011	US20110206634 Composite material for tissue repair
08/25/2011	US20110206631 Ion binding polymers and uses thereof
08/25/2011	US20110206626 Method for Treating Skin with Booster Compositions
08/25/2011	US20110206625 Compositions and methods for modulating skin pigmentation
08/25/2011	US20110206622 Effervescent Compositions Comprising Phosphonates and Methods Related Thereto
08/25/2011	US20110206620 Therapeutic Compositions for the Treatment of Dry Eye Disease
08/25/2011	US20110206613 METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
08/25/2011	US20110206612 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
08/25/2011	US20110206611 DNA Dendrimers as Thermal Ablation Devices
08/25/2011	US20110206607 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
08/25/2011	DE102010008982A1 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie A silicon-containing biologically degradable material for anti-inflammatory therapy
08/25/2011	DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy
08/25/2011	CA2827694A1 Cyclic tetrapeptides and therapeutic applications thereof
08/25/2011	CA2790790A1 Nutritional composition
08/25/2011	CA2790783A1 Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same
08/25/2011	CA2790692A1 Triazolones as fatty acid synthase inhibitors
08/25/2011	CA2790643A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
08/25/2011	CA2790641A1 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/25/2011	CA2790637A1 Pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/25/2011	CA2790602A1 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
08/25/2011	CA2790506A1 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1
08/25/2011	CA2790500A1 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
08/25/2011	CA2790401A1 Method for activation and conjugation of biomolecules
08/25/2011	CA2790332A1 Forms of rifaximin and uses thereof
08/25/2011	CA2790318A1 Novel bexarotene analogs
08/25/2011	CA2790284A1 Heterocyclic compound
08/25/2011	CA2790176A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011	CA2790164A1 Method of treating a disease condition susceptible to baclofen therapy
08/25/2011	CA2790155A1 Pyrazole derivatives as jak inhibitors
08/25/2011	CA2790095A1 Compositions comprising perfluorooctanoic acid
08/25/2011	CA2790070A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	CA2789950A1 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
08/25/2011	CA2789884A1 Solid forms comprising a cyclopropyl amide derivative
08/25/2011	CA2789872A1 Method of treating disease involving myelin and/or axonal loss
08/25/2011	CA2789821A1 Production of 6'-o-sialyllactose and intermediates
08/25/2011	CA2789757A1 Aminothiazolones as estrogen related receptor-alpha modulators
08/25/2011	CA2789753A1 Aminothiazolones as estrogen related receptor-alpha modulators
08/25/2011	CA2789711A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/25/2011	CA2789665A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
08/25/2011	CA2789655A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors
08/25/2011	CA2789408A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors
08/25/2011	CA2789406A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors
08/25/2011	CA2789259A1 Compositions and methods to treat cardiac diseases
08/25/2011	CA2789249A1 Heterocyclic compounds and uses as anticancer agents
08/25/2011	CA2789058A1 Piperidine derivatives
08/25/2011	CA2788783A1 Heterocycles as potassium channel modulators
08/25/2011	CA2788774A1 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate
08/25/2011	CA2788656A1 (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
08/25/2011	CA2788444A1 New crystalline form of a cyclopropyl benzamide derivative
08/25/2011	CA2788355A1 Phenyl-heteroaryl derivatives and methods of use thereof
08/25/2011	CA2788350A1 Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound
08/25/2011	CA2788072A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
08/25/2011	CA2787860A1 Substituted 2-imidazolidones and analogs
08/25/2011	CA2787304A1 Substituted spiroindolinones
08/25/2011	CA2787083A1 Androgen receptor modulators and uses thereof
08/25/2011	CA2786928A1 Oral smokeless tobacco products and oral smokeless non-tobacco snuff products comprising carbamide or carbamide salts
08/25/2011	CA2786294A1 Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
08/25/2011	CA2784211A1 Neuregulin antagonists and use thereof in treating cancer
08/24/2011	EP2360478A1 Molecular targets and compounds and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
08/24/2011	EP2360475A1 A method and kit for detecting the early onset of renal tubular cell injury
08/24/2011	EP2360276A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
08/24/2011	EP2360260A1 BASB006 polynucleotide(s) and polypeptides from Neisseria meningitis
08/24/2011	EP2360253A1 RNA sequence-specific mediators of RNA interference
08/24/2011	EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
08/24/2011	EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing
08/24/2011	EP2360188A1 Hyaluronic acid derivative and pharmaceutical composition thereof
08/24/2011	EP2360185A2 Administration of agents for the treatment of inflammation
08/24/2011	EP2360169A2 PSMA antibodies
08/24/2011	EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
08/24/2011	EP2360165A2 Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
08/24/2011	EP2360164A2 Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
08/24/2011	EP2360160A1 Intermediates and their use for producing benzoxazine derivative
08/24/2011	EP2360159A1 Prasugrel in micronized, crystalline form and pharmaceutical compound of same
08/24/2011	EP2360158A1 Pyrazole derivatives as jak inhibitors
08/24/2011	EP2360157A1 5-aryl isoxazolines for controlling invertebrate pests
08/24/2011	EP2360155A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity
08/24/2011	EP2360152A1 Two types of crystalline of pinocembrin: a and b, their preparation and their use for manufacture of pharmaceutical compositions
08/24/2011	EP2360151A1 Method for manufacturing neuraminic acid derivatives
08/24/2011	EP2360147A1 Process for preparing crystalline particles of a salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-quinolinone (carmoterol)

1 ... 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 ... 7860